Corcept Therapeutics Incorporated (CORT): Price and Financial Metrics

CORT POWR Grades

• Quality is the dimension where CORT ranks best; there it ranks ahead of 99.92% of US stocks.
• CORT's strongest trending metric is Growth; it's been moving up over the last 26 weeks.
• CORT ranks lowest in Momentum; there it ranks in the 18th percentile.

CORT Stock Summary

• For CORT, its debt to operating expenses ratio is greater than that reported by just 3.62% of US equities we're observing.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.21 for CORCEPT THERAPEUTICS INC; that's greater than it is for only 13.68% of US stocks.
• With a year-over-year growth in debt of -86.82%, CORCEPT THERAPEUTICS INC's debt growth rate surpasses merely 1.61% of about US stocks.
• Stocks that are quantitatively similar to CORT, based on their financial statements, market capitalization, and price volatility, are ACMR, ALRM, ALGM, WATT, and LGVN.
• Visit CORT's SEC page to see the company's official filings. To visit the company's web site, go to www.corcept.com.

CORT Valuation Summary

• In comparison to the median Healthcare stock, CORT's price/sales ratio is 236.36% higher, now standing at 7.4.
• CORT's price/sales ratio has moved NA NA over the prior 240 months.

Below are key valuation metrics over time for CORT.

CORT Growth Metrics

The 5 year cash and equivalents growth rate now stands at 122.45%.
• Its year over year net cashflow from operations growth rate is now at 23.31%.
• Its 4 year net cashflow from operations growth rate is now at 490.98%.

CORT's revenue has moved up $308,998,000 over the prior 70 months.

The table below shows CORT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	401.858	120.323	101.288
2022-09-30	397.624	136.362	116.798
2022-06-30	392.027	151.418	112.719
2022-03-31	380.229	177.717	111.844
2021-12-31	365.978	167.892	112.512
2021-09-30	352.891	153.536	106.453

CORT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CORT has a Quality Grade of A, ranking ahead of 98.86% of graded US stocks.
• CORT's asset turnover comes in at 0.616 -- ranking 52nd of 681 Pharmaceutical Products stocks.
• OTIC, ABT, and AVDL are the stocks whose asset turnover ratios are most correlated with CORT.

The table below shows CORT's key quality metrics over time.